Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Nightstar Therapeutics Ltd (NITE)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K20-F
Revenues  0.00.00.00.0
Cost of goods sold  0.00.00.00.0
Gross profit  0.00.00.00.0
Selling, general and administrative   [+]12.67.02.12.1
Research and development  31.620.510.27.2
Other operating expenses    0.00.0
EBITDA   [+]-43.9-27.3-12.1-9.3
Depreciation and amortization  0.30.20.10.0
EBIT   [+]-44.2-27.5-12.2-9.3
Interest income  2.90.70.00.0
Other income (expense), net  4.0-2.90.0-4.3
Pre-tax income  -37.3-29.6-12.2-13.6
Income taxes  -0.40.00.00.0
            Tax rate  1.2% 0.0%0.0%
Net income  -36.9-29.7-12.2-13.6
   
Basic EPS   [+]($1.26)($1.63)($1.36)($2.46)
Diluted EPS   [+]($1.26)($1.63)($1.36)($2.46)
   
Shares outstanding (basic)   [+]29.218.29.05.5
Shares outstanding (diluted)   [+]29.218.29.05.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy